Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
bGTxRmPcw4HKhSEA
